Browsing Tag
dsm-firmenich
4 posts
EUROAPI targets North American compounding market through MEDISCA as peptide strategy expands
EUROAPI has entered a strategic distribution partnership with MEDISCA to expand European-manufactured pharmaceutical ingredient access in North America and explore peptide opportunities. The agreement offers a potential route to new customers as EUROAPI restructures its manufacturing business, but undisclosed contract economics and tightening US compounding regulations leave its financial impact uncertain.
Could Ingredion’s Tate & Lyle deal reshape the global specialty ingredients market?
Find out how Ingredion’s Tate & Lyle deal could reshape specialty ingredients, sugar reduction, and INGR stock sentiment.
DSM-Firmenich’s surprise move: Apollo gets a second shot as CVC falters in nutrition deal
DSM-Firmenich reopens its ANH auction as CVC’s bid falters, bringing Apollo back into play. Find out what this means for global nutrition M&A.
No cows, no problem – Vivici lands €32.5m to scale precision fermentation dairy proteins
Vivici, the Netherlands-based food biotechnology company, has raised €32.5 million (approximately US $33.7 million) in a Series A…